Biomarkers of Myocardial Stress and Systemic Inflammation in Patients Who Engage in Heart Failure Self-care Management

Background:Self-care is believed to improve heart failure (HF) outcomes, but the mechanisms by which such improvement occurs remain unclear. Methods:We completed a secondary analysis of cross-sectional data collected on adults with symptomatic HF to test our hypothesis that effective self-care is associated with less myocardial stress and systemic inflammation. Multivariate logistic regression modeling was used to determine if better HF self-care reduced the odds of having serum levels of amino-terminal pro-B-type natriuretic peptide and soluble tumor necrosis factor &agr; receptor type 1 at or greater than the sample median. Heart failure self-care was measured using the Self-care of Heart Failure Index. Results:The sample (n = 168) was predominantly male (65.5%), and most (50.6%) had New York Heart Association III HF (mean left ventricular ejection fraction, 34.9% [SD, 14.0%]); mean age was 58.8 (SD, 11.5) years. Self-care management was an independent factor in the model (block &khgr;2 = 14.74; P = .005) after controlling for pertinent confounders (model &khgr;2 = 52.15; P < .001). Each 1-point increase in self-care management score (range, 15-100) was associated with a 12.7% reduction in the odds of having levels of both biomarkers at or greater than the sample median (adjusted odds ratio, 0.873; 95% confidence interval, 0.77-0.99; P = .03). Conclusion:Better self-care management was associated with reduced odds of myocardial stress and systemic inflammation over and above pharmacological therapy and other common confounding factors. Teaching HF patients early symptom recognition and self-care of symptoms may decrease myocardial stress and systemic inflammation.

[1]  G. Schuler,et al.  Invasive assessment of bacterial endotoxin and inflammatory cytokines in patients with acute heart failure , 2003, European journal of heart failure.

[2]  D. Fliser,et al.  Antiinflammatory Effects of Angiotensin II Subtype 1 Receptor Blockade in Hypertensive Patients With Microinflammation , 2004, Circulation.

[3]  C. Musil,et al.  Recurrent symptoms: well-being and management. , 2001, Social science & medicine.

[4]  K. Lorig,et al.  Self-management education: History, definition, outcomes, and mechanisms , 2003, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[5]  B. Riegel,et al.  Gender differences in and factors related to self-care behaviors: a cross-sectional, correlational study of patients with heart failure. , 2008, International journal of nursing studies.

[6]  M. Emdin,et al.  The Circulating Levels of Cardiac Natriuretic Hormones in Healthy Adults: Effects of Age and Sex , 2002, Clinical chemistry and laboratory medicine.

[7]  S. Stewart,et al.  Measuring Self-care in Chronic Heart Failure: A Review of the Psychometric Properties of Clinical Instruments , 2009, The Journal of cardiovascular nursing.

[8]  G. Torre-Amione Immune activation in chronic heart failure. , 2005, The American journal of cardiology.

[9]  H. Ruskoaho Cardiac hormones as diagnostic tools in heart failure. , 2003, Endocrine reviews.

[10]  Haske van Veenendaal,et al.  Effectiveness of self-management interventions on mortality , hospital readmissions , chronic heart failure hospitalization rate and quality of life in patients with chronic heart failure : A systematic review , 2010 .

[11]  M. Drazner,et al.  Impact of Body Mass and Body Composition on Circulating Levels of Natriuretic Peptides: Results From the Dallas Heart Study , 2005, Circulation.

[12]  R. Dantzer,et al.  Named Series: Twenty Years of Brain, Behavior, and Immunity Twenty years of research on cytokine-induced sickness behavior , 2007 .

[13]  J. Cohn,et al.  Relationships between clinical assessments and patients' perceptions of the effects of heart failure on their quality of life. , 2006, Journal of cardiac failure.

[14]  J. H. Patterson,et al.  Executive Summary Executive Summary : HFSA 2010 Comprehensive Heart Failure Practice Guideline , 2022 .

[15]  G. Novo,et al.  Biomarkers in heart failure. , 2009, Frontiers in bioscience.

[16]  B. Riegel,et al.  A Situation-Specific Theory of Heart Failure Self-care , 2008, The Journal of cardiovascular nursing.

[17]  B. Riegel,et al.  The Influence of Heart Failure Self-care on Health Outcomes: Hypothetical Cardioprotective Mechanisms , 2009, The Journal of cardiovascular nursing.

[18]  A. Ferreira,et al.  The effect of dietary sodium restriction on neurohumoral activity and renal dopaminergic response in patients with heart failure , 2004, European journal of heart failure.

[19]  V. Hasselblad,et al.  Dissociation between hemodynamic changes and symptom improvement in patients with advanced congestive heart failure , 2002, European journal of heart failure.

[20]  A. Ferreira,et al.  Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure. , 2004, International journal of cardiology.

[21]  J. Morrow,et al.  Intraindividual Variability of Plasma Antioxidants, Markers of Oxidative Stress, C-Reactive Protein, Cotinine, and Other Biomarkers , 2006, Epidemiology.

[22]  L. Allen,et al.  Multi-marker strategies in heart failure: clinical and statistical approaches , 2010, Heart Failure Reviews.

[23]  D. Morrow,et al.  Benchmarks for the Assessment of Novel Cardiovascular Biomarkers , 2007, Circulation.

[24]  M. Packer The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. , 1992, Journal of the American College of Cardiology.

[25]  L. Appel,et al.  State of the science: promoting self-care in persons with heart failure: a scientific statement from the American Heart Association. , 2009, Circulation.

[26]  Anders Larsson,et al.  Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. , 2008, The New England journal of medicine.

[27]  W. Shadish,et al.  Experimental and Quasi-Experimental Designs for Generalized Causal Inference , 2001 .

[28]  S. Frøland,et al.  Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure. , 1999, Journal of the American College of Cardiology.

[29]  B. Bozkurt,et al.  Basic mechanisms in heart failure: the cytokine hypothesis. , 1996, Journal of cardiac failure.

[30]  J. V. D. van den Ouweland,et al.  High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. , 2004, Clinical chemistry.

[31]  M. Sebern,et al.  Psychometric testing of the self-care of heart failure index. , 2004, Journal of cardiac failure.

[32]  B. Riegel,et al.  Abstract 2510: Nonadherence is a Mediator of the Link Between Depressive Symptoms, and Rehospitalization or Mortality in Patients with Heart Failure , 2006 .

[33]  R. Tate,et al.  Determinants of Self-care Behaviors in Community-Dwelling Patients With Heart Failure , 2009, The Journal of cardiovascular nursing.

[34]  R. Dantzer,et al.  Cytokine-induced sickness behavior , 2003, Brain, Behavior, and Immunity.

[35]  S. Anker,et al.  Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure , 2000, Circulation.

[36]  N. Khaper,et al.  Inflammatory cytokines and postmyocardial infarction remodeling. , 2004, Circulation research.

[37]  Stephan von Haehling,et al.  Inflammatory mediators in chronic heart failure: an overview , 2004, Heart.

[38]  J. Heywood,et al.  Optimal use of diuretics in patients with heart failure , 2007, Current treatment options in cardiovascular medicine.

[39]  A. Kızıltunç,et al.  The Effect of Beta‐Blocker (Carvedilol) Therapy on N‐Terminal Pro‐Brain Natriuretic Peptide Levels and Echocardiographic Findings in Patients with Congestive Heart Failure , 2007, Echocardiography.

[40]  K. Dickstein,et al.  Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients. , 2005, Journal of the American College of Cardiology.

[41]  P. Allison Multiple Regression: A Primer , 1994 .

[42]  M. Nieminen,et al.  Clinical applications of B-type natriuretic peptide (BNP) testing. , 2003, European heart journal.

[43]  J. Ulrich [Physiology of the heart]. , 1950, Zeitschrift fur Kreislaufforschung.

[44]  B. Riegel,et al.  The Relationship Between Self-Care and Health Status Domains in Thai Patients with Heart Failure , 2009, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[45]  A. Hoffmeier,et al.  Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[46]  B. Riegel,et al.  Event-free survival in adults with heart failure who engage in self-care management. , 2011, Heart & lung : the journal of critical care.

[47]  J. Thornby,et al.  Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials. , 1999, Journal of the American College of Cardiology.

[48]  B. Riegel,et al.  Predictors of self-care in persons with heart failure. , 1999, Heart & lung : the journal of critical care.

[49]  T. Ueland,et al.  Inflammatory and anti‐inflammatory cytokines in chronic heart failure: Potential therapeutic implications , 2005, Annals of medicine.

[50]  Anita Deswal,et al.  Cytokines and Cytokine Receptors in Advanced Heart Failure: An Analysis of the Cytokine Database from the Vesnarinone Trial (VEST) , 2001, Circulation.

[51]  S. Rajagopalan,et al.  Statin therapy is associated with improved cardiovascular outcomes and levels of inflammatory markers in patients with heart failure. , 2005, Journal of cardiac failure.

[52]  J. Goetze Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited. , 2004, Clinical chemistry.

[53]  A. Jaffe,et al.  National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biomarkers of heart failure. , 2007, Clinical biochemistry.

[54]  Harleah G. Buck,et al.  "Determinants of self-care behaviors in community-dwelling patients with heart failure". , 2009, The Journal of cardiovascular nursing.

[55]  I. Squire,et al.  Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate , 2003, European journal of heart failure.

[56]  C. Zambroski Self-care at the End of Life in Patients With Heart Failure , 2008, The Journal of cardiovascular nursing.

[57]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[58]  F. van Lente,et al.  Plasma B-Type Natriuretic Peptide Levels in Ambulatory Patients With Established Chronic Symptomatic Systolic Heart Failure , 2003, Circulation.